Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. | Walmart ...

“Where this dead retina was a complete blind spot, vision was restored,” Dr. Frank Holz, the study’s lead author and an ...

An electronic retinal implant has improved vision in people with age-related macular degeneration—but it isn’t a full ...

Want to putt like the pros? Ian Poulter shows how a simple string can improve your putting alignment, eye position and stroke.

Butler Library for Buffalo State students is one of the most powerful resources you can find on campus. With access to ...

This video features freestyle soccer duels where awareness and control guided the play. Players used anticipation, ...

Norwegian Cruise Line has stopped delivering the Freestyle Daily newsletter, but cruisers can still pick up copies onboard.

Can your bathroom double as a lab? At-home testing is reshaping how we learn about our bodies — and raising new questions.

Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...

The Trends in Travel™. The annual global report highlights shifts in traveller behavior and the destinations set to dominate ...

On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.

Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.